A sound rebound: long-awaited economic growth helped Barbara Bowles' stock selections prosper.Last year, Barbara L. Bowles, founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of The Kenwood Group, a Chicago-based equity management services firm, estimated that an economic rebound was on the horizon--and it wasn't far from the truth. When she supplied BLACK ENTERPRISE with a portfolio of five companies Bowles looked for mid- to large-cap companies that carried little debt and had been able to take advantage of economic policies designed to encourage corporate growth. Bowles, a former investor relations Investor relations The process by which the corporation communicates with its investors. chief at Kraft Inc. and Beatrice Companies Inc., suggested that technology and materials companies were most likely to expand production and staffing in 2004, but she didn't limit her selections to those sectors. Although the rebound hasn't been as robust as many analysts predicted, the economy has experienced steady improvement and Bowles' picks have benefited. Bowles' portfolio yielded a 22.50% return over the 32-week period from Nov. 13, 2003, to Nov. 12, 2004. In comparison, the S&P 500 rose 11.88% and the Dow Jones Industrial Average Dow Jones Industrial Average The best known U.S. index of stocks. A price-weighted average of 30 actively traded blue-chip stocks, primarily industrials including stocks that trade on the New York Stock Exchange. rose 7.13% during the same period. Securities products and services firm Kroll Inc.*** was the biggest winner for Bowles. She felt positive about the future earning potential of the company's accounting and background screening divisions. Marsh & McLennan Cos, felt the same way and paid $1.9 billion to acquire the obscure New York City-based company, which also offers computer forensics, data recovery, and corporate restructuring services. The stock was trading at $28.10 when it was acquired, but the agreement included a cash buyout at $37 per share, which resulted in the stock producing a total return of 57.58%. The worst performing stock for Bowles was Western Digital Corp. (NYSE NYSE See: New York Stock Exchange : WDC WDC Washington DC, USA WDC Western Digital Corporation WDC World Data Center WDC Warwick District Council (UK) WDC World Diamond Council WDC Workforce Development Center WDC Wisconsin Democracy Campaign ). The company lost 31.63%, sliding from $13.15 to $8.99 a share, but Bowles still believes the company should reach the 12- to 18-month target price of $17 that she set for it. "We are still holding it. We believe they have adjusted to the [economic] environment, meaning they really had to take down inventory because there was too much [of it] in the disk drive industry." The Kenwood Group sold Renal Care Group Inc. (NYSE: RCI RCI Royal Caribbean International RCI Radio Canada International RCI Rehabilitation Council of India RCI Residential Communities Initiative RCI Roof Consultants Institute RCI Remote Control Interface RCI Residential, Commercial, Industrial ) in May before the stock split 3-for-2. "We sold this at a very good price and at full value because the stock has not moved since [November 2004]," says Bowles of the dialysis services company. Had the stock been held for an entire year, it would have increased 27.10% to $33.49, adjusted for the stock split. Another healthcare stock, Becton Dickinson & Co. (NYSE: BDX BDX Bordeaux (France) BDX Becton-Dickinson and Company (stock symbol) BDX Business Document Exchange BDX Burst Detector X BDX Beacon Data Extractor ), also did well. Selling at $37.24 at the time of recommendation, Becton Dickinson jumped to $54.27, yielding a 45.73% gain. "This stock is still in our portfolio. However, we recently cut our position back," says Bowles. "We would consider it a hold and not a buy at this price." Finally, The Kenwood Group cut back its holdings of Janus Capital Group Janus Capital Group Inc. is a public company headquarted in Denver, CO, US. It was founded in 1969. It provides risk-managed investment strategies. As of June 30, 2007, Janus managed $190. Inc, (NYSE: JNS JNS Journal of Neurosurgery JNS Jump If No Sign JNS Narssaq, Greenland (Airport Code) JNS Journal of Neoplatonic Studies JNS Justification for New Start ). Bowles saw the mutual fund firm as a good buy at $13.86 a year ago and forecasted that the stock could reach as high as $18 in a 12- to 18-month period. Janus' stock price actually rose to $15.76, a gain of 13.71%. Bowles says, "We cut back a little sooner than our fair value target because the company has been slow to gain traction in a very competitive mutual fund industry." [GRAPHICS OMITTED] |
|
||||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion